Looking to publish in Current Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowCurrent Gene Therapy is a journal in gene therapy with ISSN 1566-5232 (print) and 1875-5631 (online). It has an Impact Factor of 3.3, is indexed in Scopus, SCI Expanded, and MEDLINE/PubMed, and publishes Volume 26 in 2026. The journal offers online manuscript submission and includes both subscription content and open access articles.
Looking to publish in Current Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Current Gene Therapy accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Mini-Reviews
Systematic Reviews
Meta-Analyses
Research Articles
Randomized Drug Clinical Trial Studies
Short Communications
Letters
Case Reports
Recent Publications
Surface Functionalization of 3D-Printed Porous Ti-6Al-4V Scaffolds with PDA‑mHA-Col I Composite Coating Drives Macrophage Polarization toward the M2 Phenotype and Promotes Immunomodulation: An In Vitro Study
Xu Han, Hailong Yuan, Yi Xiao, Zhen Tang, Gang Tian, Jianyong Gao, Qi Cai, Lisong Lin, Xiaogang Xu
Single‑cell Transcriptomic Profiling of Bone Marrow Mesenchymal Stem Cells Reveals Lineage Heterogeneity and Dysregulated Osteoblast Genes in Osteoporosis Versus Osteoarthritis
Houlei Wang, Chenyang Zhuang, Tianle Ma, Hong Lin
A Telomere-Maintenance Three-Gene Model for the Prognostic Prediction in Intrahepatic Cholangiocarcinoma and Multi-Cohort Validation
Lihua Wang, Wenjing Zhao, Zhongfeng Cui, Guangming Li
APOL3 Orchestrates Metastasis and Enzalutamide Resistance via STAT3-DAB2IP Signaling in Prostate Cancer
Quanxin Wang, Songlin Zuo, Lin Chen, Fangning Wan, Zhe Hong, Wenhao Xu, Wenting Hou, Dingwei Ye
HOXC4 Is Associated with the Prognosis and Immune Cell Infiltration in the Progression of Prostate Cancer
Zhenhong Chen, Dujuan Wang, Yongkang Xie, Zhongjin Fang, Jianjing Wang, Zhaocun Yu, Zaoqing Chen, Yanhui Zou, Zhongning Chen, Qianhai Liu, Huasheng Huang
Frequently asked questions
How long does it take to publish?
Quick Track allows online publication within 2 weeks of receipt of the final approved galley proofs and 10 weeks from first receipt of the manuscript to online publication, subject to acceptance and author revisions within one week. Revised papers are usually requested within 15 days, with revision time varying from 1 to 4 weeks. Proofs should be returned within 48 hours.
Reformat to Current Gene Therapy using Livewrite PremiumIs a cover letter required?
A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.
Reformat to Current Gene Therapy using Livewrite PremiumWhat are the publication costs?
Publication charges are US $690 for research articles, US $190 for short communications/letters, and US $290 for review articles. Optional Gold Open Access costs US $3633 per article for general submissions and US $1900 for thematic issues.
Reformat to Current Gene Therapy using Livewrite Premium